International Women's Day, celebrated globally on March 8, honors women's roles and achievements. Originating in the early 20th century, the day advocates for gender equality. The 2025 theme is ...

A total of 1,693 shareholders were present at the meeting held in Basel, representing approximately 57.42% of the issued shares of Novartis. With a dividend increase of 6.1% to CHF 3.50 per share, ...

He was reportedly carrying fliers bearing the slogan “Long Live President Yoon!” Officials said he was hospitalized in critical condition.

A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by ...

ZURICH, Feb 26 (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis (NOVN.S), opens new tab ...

Novartis AG failed to show that it will suffer harm from a Missouri law that requires it to discount drugs to an unlimited number of pharmacies under the 340B Drug Pricing Program, a federal judge ...

Switzerland-based Novartis has one of the strongest and broadest portfolios of varied drugs that has enabled it to maintain its dominant position as a top pharma company over the years.

ZURICH, Feb 25 (Reuters) - Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss pharmaceutical firm Novartis to raise up to $3 ...

In Chitradurga, Karnataka, activists halted an MSRTC bus, defaced it, and blackened the driver’s face while chanting slogans. Due to these incidents, interstate bus services between Maharashtra and ...

Swiss drugmaker Novartis is suing Australia’s biggest cancer care provider, GenesisCare, for alleged patent infringement in a Federal Court case that escalates a dispute between pharmaceutical ...

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug price negotiation program enacted under President Joe Biden.

When it passed over the objections of free speech advocates, European Commission Executive Vice President Margrethe Vestager was perfectly ecstatic, declaring it is “not a slogan anymore ...